Insider · CIK 0001908071
John Stephen Healy
Files at CTNM (Contineum Therapeutics, Inc.). First filing -, latest -.
In brief
John Stephen Healy files SEC Form 4 as officer at CTNM (Contineum Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John Stephen Healy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | CTNM Contineum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +206,411 | $0.00 | $0 | 206,411 | Jan 30, 2026 |
| Jan 31, 2025 | CTNM Contineum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +63,589 | $0.00 | $0 | 63,589 | Jan 31, 2025 |
Questions about John Stephen Healy
Answered from the filings on this page, as of the latest one.
Is John Stephen Healy buying or selling?
John Stephen Healy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John Stephen Healy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Stephen Healy has 0.
Where does John Stephen Healy file Form 4?
John Stephen Healy has filed Form 4 at CTNM (Contineum Therapeutics, Inc.) as General Counsel and Corp Sec. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.